← Back to Search

Behavioral Intervention

Lifestyle Program for Endometrial Cancer Survivors

N/A
Recruiting
Led By Kari Ring, MD
Research Sponsored by University of Virginia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have no evidence of endometrial cancer as determined by primary oncologist
Be at least 18 years of age
Must not have
Subject is blind
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 7 and week 32
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to help endometrial cancer survivors make positive lifestyle changes to reduce the risk of other health conditions. The University of Virginia is testing a program called the Anticancer Lifestyle program, which

Who is the study for?
This trial is for endometrial cancer survivors over 18, with no current evidence of cancer. Participants must be able to read and communicate in English, have access to a smartphone or computer with internet, and be willing to follow the study procedures for its duration.
What is being tested?
The Anticancer Learning Circle Lifestyle Program is being tested. It's a holistic approach that combines web-based learning modules with weekly group discussions aimed at promoting healthier lifestyles among endometrial cancer survivors.
What are the potential side effects?
Since this program focuses on lifestyle changes rather than medication, traditional side effects are not expected. However, participants may experience changes in mood or stress levels due to lifestyle adjustments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My oncologist confirmed I don't have endometrial cancer.
Select...
I am 18 years old or older.
Select...
I have had endometrial cancer at any stage.
Select...
I have finished my cancer treatment and am now in follow-up care.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am legally blind.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 7 and week 32
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 7 and week 32 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of participants that complete the program
Secondary study objectives
Assess Attitudes Toward Group-Based Lifestyle Therapy Program Utilizing Internal Scale at Week 7 and Week 32
Change from Week 0 of Generalized Anxiety Disorder (GAD-7) Survey from Baseline at Week 32
Change from Week 0 of the Automated Self-administered 24-hour Dietary Assessment (ASA24) at Week 7
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Anticancer Learning Circle ParticipantExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University of VirginiaLead Sponsor
782 Previous Clinical Trials
1,315,677 Total Patients Enrolled
Kari Ring, MDPrincipal InvestigatorUniversity of Virginia
1 Previous Clinical Trials
96 Total Patients Enrolled
~17 spots leftby May 2025